LifeSemantics, Lifeceutical’s well being meals division because of and integration … Efficiency enchancment is anticipated

[이데일리 김승권 기자] Life Semantics (347700)We’ll focus our efforts on enhancing the monetary construction and rising gross sales to speed up the conclusion of medical AI.

LifeSemantics introduced on the first that it’ll spin off and merge with the purposeful well being meals enterprise division of its subsidiary, Lifeceutical.

LifeSemantics held a board assembly on June 28 and selected one other merger plan. The merger date is September 1, and LifeSemantics owns 100% of the shares of LifeSemantics, so this merger shall be effected as a non-capital merger with no change to LifeSemantics’ post-merger consolidated monetary statements and no new inventory problem. The combination ratio is 1:0.

Brand of LifeSemantics

Following this different merger, the belongings and liabilities of Lifeceutical’s purposeful well being meals enterprise section shall be transferred to LifeSemantics. Lifeceuticals was established in 2023 with a 100% funding by LifeSemantics, and the purposeful well being meals enterprise division was integrated into the mum or dad firm, so there isn’t a change within the consolidated monetary statements.

LifeSemantics plans to speed up its core medical AI enterprise by enhancing money circulation and in search of efficiency progress by way of the merger of the well being meals enterprise, which has a transparent gross sales progress development. Of the 1.6 billion gained in gross sales recorded by Lifeceuticals within the first quarter, 800 million gained, or half, was generated from the well being purposeful meals trade, so LifeSemantics has a gross sales mannequin to generate income in time to get a future.

The monetary construction of Lifeceutical, a subsidiary, can also be anticipated to enhance. Because the purposeful well being meals enterprise division was break up off and merged with the mum or dad firm, the debt of Lifeceutical, the surviving entity, was decreased, and the corporate was capable of lay a basis for company progress by focuses its essential capabilities and assets on drugs. enterprise sector, that are additionally optimistic modifications because of this merger It’s one in every of them.

Kim Tae-hyun, CFO of LifeSemantics, stated, “This merger is a significant choice that creates a win-win state of affairs for each the mum or dad firm and its subsidiaries.” He added, “We’ll develop the achievement of medical AI by way of higher efficiency of LifeSemantics and the revitalization of the Lifeceutical pharmaceutical trade.